| Kimberly Ann Haviland, LCSW, CDCI, ADMIN | |
|
11312 Kenai Spur Hwy, Suite 39, Kenai, AK 99611-7754 | |
| (907) 395-4106 | |
| (907) 283-4236 |
| Full Name | Kimberly Ann Haviland |
|---|---|
| Gender | Female |
| Speciality | Social Worker - Clinical |
| Location | 11312 Kenai Spur Hwy, Kenai, Alaska |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1881805984 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 1041C0700X | Social Worker - Clinical | 864 (Alaska) | Primary |
| 101YA0400X | Counselor - Addiction (substance Use Disorder) | 2432 (Alaska) | Secondary |
| Mailing Address | Practice Location Address |
|---|---|
| Kimberly Ann Haviland, LCSW, CDCI, ADMIN 11312 Kenai Spur Hwy, Suite 39, Kenai, AK 99611-7754 Ph: (907) 395-4106 | Kimberly Ann Haviland, LCSW, CDCI, ADMIN 11312 Kenai Spur Hwy, Suite 39, Kenai, AK 99611-7754 Ph: (907) 395-4106 |
News Archive
Taiwan has apparently responded to bird flu fears by starting work on its own version of the anti-viral drug, Tamiflu, without waiting for the manufacturer's consent.
New research shows improved smoking cessation outcomes can be achieved within the Medi-Cal (California's Medicaid program) population by supplementing telephone counseling with access to nicotine-replacement patches and moderate financial incentives that are not contingent on outcomes.
A drug in testing to treat atherosclerosis significantly inhibited growth of ovarian cancer in both human cell lines and mouse models, the first such report of a peptide being used to fight malignancies, according to a study by researchers at UCLA's Jonsson Comprehensive Cancer Center.
A component of the human interferon system that activates SARS-CoV-2 cellular defenses appears to be defective in a proportion of humans, new research reports. COVID-19 outcomes were more severe in hospitalized patients who exhibited this immune system deficit, the study shows.
Yissum Research Development Company Ltd., the technology transfer company of the Hebrew University of Jerusalem, and Hadasit Medical Research Services & Development Ltd., the technology transfer company of the Hadassah University Medical Center, today announced that they have licensed innovative regenerative membrane implant technology to RegeneCure, which will further develop and commercialize the technology for bone tissue engineering for applications in trauma, spine, and reconstructive cranial and facial orthopedics.
› Verified 9 days ago
Michael J Wolfe, LCSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 110 N Willow St, Kenai, AK 99611 Phone: 907-283-6693 Fax: 907-283-7088 | |
Leah Williamson, Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 609 Marine Ave, Kenai, AK 99611 Phone: 076-001-6849 Fax: 907-308-5882 | |
Ms. Erys Katherine Tea, LCSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 215 Fidalgo Avenue, Suite 204 C, Kenai, AK 99611 Phone: 907-283-6551 Fax: 907-283-6553 | |
Fridrik Rafn Gudmundsson, L.C.S.W. Clinical Social Worker Medicare: Medicare Enrolled Practice Location: 510 Upland St, Kenai, AK 99611 Phone: 907-335-7315 Fax: 888-491-3243 | |
Mrs. Terrya Elder, LCSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 320 S Spruce St, Kenai, AK 99611 Phone: 907-283-7635 Fax: 907-283-9575 |